These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6360762)

  • 1. Reduced solubility of short-acting soluble insulins when mixed with longer-acting insulins.
    Nolte MS; Poon V; Grodsky GM; Forsham PH; Karam JH
    Diabetes; 1983 Dec; 32(12):1177-81. PubMed ID: 6360762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility changes on mixing short- and long-acting insulin preparations.
    Havlik I; Galasko G; Alberts E; Furman KI; Seftel HC
    S Afr Med J; 1988 Mar; 73(6):361-2. PubMed ID: 3281288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO; Hans A; Henning VS
    Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing effect of mixing insulins by glucose-clamp technique in subjects with diabetes mellitus.
    Colagiuri S; Villalobos S
    Diabetes Care; 1986; 9(6):579-86. PubMed ID: 3542452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
    Heine RJ; Bilo HJ; Fonk T; van der Veen EA; van der Meer J
    Diabetologia; 1984 Dec; 27(6):558-62. PubMed ID: 6397384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixing insulins in 1990.
    Anderson JH; Campbell RK
    Diabetes Educ; 1990; 16(5):380-7. PubMed ID: 2202572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes.
    Best JD; Ley CJ; Strauss BJ; Alford FP; Aitken PM
    Med J Aust; 1987 Jun; 146(12):621-3, 627. PubMed ID: 3306298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T
    Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
    Goicolea I; Quiroga A; Vazquez JA
    Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day].
    Cucinotta D; Lunetta M
    Minerva Endocrinol; 1990; 15(2):111-6. PubMed ID: 2098651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different daily blood glucose control and free insulin levels during treatment with mixtures of soluble and lente or soluble and NPH semisynthetic human insulins.
    Cucinotta D; Di Benedetto A; Gigante A; Di Cesare E; Musolino C; Squadrito G
    Diabete Metab; 1989; 15(4):182-7. PubMed ID: 2680669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of soluble insulin in mixed preparations of crystalline and ultralente biosynthetic human insulin.
    Huffman DM; Garber AJ
    Clin Ther; 1991; 13(2):232-8. PubMed ID: 1863938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and miscibility of 4 highly purified porcine insulins: a study in vitro and in healthy volunteers.
    Heine RJ; Van der Stap H; Salemink PJ; Kolkman-Roodbeen JC; Banken P; Gribnau TC; van der Veen EA
    Diabetes Res; 1987 Jan; 4(1):45-50. PubMed ID: 3552367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
    Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
    Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.
    Schulz B; Menzel R; Besch W
    Exp Clin Endocrinol; 1988 Mar; 91(1):27-34. PubMed ID: 3286272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
    Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
    Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in solubility of insulin in therapeutic mixtures of insulin preparations: HPLC analysis.
    Arakawa Y; Kurokawa N; Maeda Y; Yanaihara C
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S93-100. PubMed ID: 2680372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting insulins alter milk composition and metabolism of lactating dairy cows.
    Winkelman LA; Overton TR
    J Dairy Sci; 2013; 96(12):7565-77. PubMed ID: 24119807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection.
    Francis AJ; Hanning I; Alberti KG
    Diabet Med; 1985 May; 2(3):177-80. PubMed ID: 2952414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.